[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 999 0232", "website": "https://www.q32bio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti\u0096interleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb \u0096 CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Ms. Jodie Pope Morrison", "age": 48, "title": "CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 860740, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee H. Kalowski M.B.A.", "age": 43, "title": "CFO & President", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 750793, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shelia M. Violette Ph.D.", "age": 63, "title": "Co-founder, Chief Scientific Officer & President of Research", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 619930, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Saul W. Fink Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Appugliese J.D.", "title": "Senior VP & Head of People", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maria  Marzilli M.P.H.", "title": "Executive Vice President of Corporate Strategy & Program Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adrien  Sipos", "title": "Interim Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.2, "open": 3.21, "dayLow": 3.0568, "dayHigh": 3.245, "regularMarketPreviousClose": 3.2, "regularMarketOpen": 3.21, "regularMarketDayLow": 3.0568, "regularMarketDayHigh": 3.245, "payoutRatio": 0.0, "forwardPE": -0.5970149, "volume": 145924, "regularMarketVolume": 145924, "averageVolume": 3093325, "averageVolume10days": 219460, "averageDailyVolume10Day": 219460, "bid": 2.87, "ask": 3.02, "bidSize": 1, "askSize": 1, "marketCap": 39373928, "fiftyTwoWeekLow": 1.345, "fiftyTwoWeekHigh": 6.37, "allTimeHigh": 572.4, "allTimeLow": 1.345, "fiftyDayAverage": 2.7794, "twoHundredDayAverage": 2.128675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7359926, "profitMargins": 0.0, "floatShares": 5527607, "sharesOutstanding": 12304352, "sharesShort": 428900, "sharesShortPriorMonth": 277802, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0349, "heldPercentInsiders": 0.064840004, "heldPercentInstitutions": 0.64416003, "shortRatio": 0.05, "shortPercentOfFloat": 0.121199995, "impliedSharesOutstanding": 12304352, "bookValue": -1.499, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -42098000, "trailingEps": -3.4, "forwardEps": -5.36, "lastSplitFactor": "1:18", "lastSplitDate": 1711411200, "enterpriseToEbitda": -0.171, "52WeekChange": 0.02893889, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 3.2, "targetHighPrice": 20.0, "targetLowPrice": 10.0, "targetMeanPrice": 15.0, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 49039000, "totalCashPerShare": 3.986, "ebitda": -43082000, "totalDebt": 17025000, "quickRatio": 4.464, "currentRatio": 4.573, "returnOnAssets": -0.335, "grossProfits": -26386000, "freeCashflow": -24365876, "operatingCashflow": -38791000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QTTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekLowChange": 1.855, "fiftyTwoWeekLowChangePercent": 1.3791821, "fiftyTwoWeekRange": "1.345 - 6.37", "fiftyTwoWeekHighChange": -3.1699998, "fiftyTwoWeekHighChangePercent": -0.4976452, "fiftyTwoWeekChangePercent": 2.893889, "marketState": "CLOSED", "averageDailyVolume3Month": 3093325, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.4, "epsForward": -5.36, "postMarketChangePercent": 0.0, "postMarketPrice": 3.2, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "3.0568 - 3.245", "fullExchangeName": "NasdaqCM", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1522243800000, "corporateActions": [], "postMarketTime": 1766792990, "regularMarketTime": 1766782800, "exchange": "NCM", "messageBoardId": "finmb_669405676", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 0.42059994, "fiftyDayAverageChangePercent": 0.1513276, "twoHundredDayAverageChange": 1.0713251, "twoHundredDayAverageChangePercent": 0.5032826, "priceToBook": -2.1347566, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "regularMarketChangePercent": 0.0, "regularMarketPrice": 3.2, "cryptoTradeable": false, "shortName": "Q32 Bio Inc.", "longName": "Q32 Bio Inc.", "displayName": "Q32 Bio", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]